Lobular carcinoma in situ diagnosed by core needle biopsy: When should it be excised?

Modern Pathology

Volumn 16, Issue 2, 2003, Pages 120-129

  Middleton, Lavinia P ^a   Grant, Shakeitha ^a   Stephens, Tanya ^a   Stelling, Carol B ^a   Sneige, Nour ^a   Sahin, Aysegul A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Atypical lobular hyperplasia; Core needle biopsy; Lobular carcinoma in situ; Pathology; Radiology

Indexed keywords

TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; BREAST ADENOMA; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL ARTICLE; CORE NEEDLE BIOPSY; DIAGNOSTIC TEST; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; MEDICAL RECORD; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; MAMMOGRAPHY; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES;

EID: 0037330732     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000051930.68104.92     Document Type: Article

References (22)

1. Tabor L, Vitak B, Chen HH, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-31.
2. Foote FW, Stewart FW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol 1941;17:491-5.
3. Page DL, Kidd TE Jr, Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-9.
4. O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy - what is the clinical significance? Clin Radiol 2001;56:216-20.
5. Haagensen CD, Lane N, Lattes R, et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
6. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301.
7. Rosen PP, Kosloff C, Lieberman PH, et al. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978;2:225-51.
8. Page DL, Anderson TJ, Rogers LN. Lobular carcinoma in situ. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. New York: Churchill Livingston, 1987:174-82.
9. Fisher B, Constantino JP, Wickerman DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
10. Bassett L, Winchester DP, Caplan RB, et al. Stereotactic core needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists. CA Cancer J Clin 1997;47:171-90.
11. Fraser JL, Raza S, Chorny, et al. Columnar alteration with prominent apical snouts and secretions. Am J Surg Pathol 1998;22:1521-7.
12. Snyder RE. Mammography and lobular carcinoma in situ. Surg Gynecol Obstet 1966;22:225-60.
13. Hutter RVP, Snyder RE, Lucas JC, et al. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer 1969;24:826-39.
14. Pope TL, Fechner RE, Wilhelm MC, et al. Lobular carcinoma in situ of the breast: mammographic features. Radiology 1988;168:63-6.
15. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 1999;173:291-9.
16. Lechner MC, Jackman RJ, Brem RF, et al. Lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study. Radiology 1999;213(P):106.
17. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000;216:831-83.
18. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001;218:503-9.
19. Pacelli A, Rhodes DJ, Amrami KK, et al. Outcome of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed by core needle biopsy: clinical and surgical follow-up of 30 cases. Am J Clin Pathol 2001;116:591-2.
20. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002;126:697-701.
21. Hoda SA, Rosen PP. Practical considerations in the pathologic diagnosis of needle core biopsies of breast. Am J Clin Pathol 2002;118:101-8.
22. Renshaw AE, Cartagena N, Derhagopian RP. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002;117:797-9.